Ronnie Andrews

Ronnie has over 35 years of experience in the Global Clinical and Molecular Diagnostics industry. He currently serves as the President and CEO of Oncocyte Inc. In his early years in diagnostics, he worked for Abbott Diagnostics in sales and marketing, Immucor as VP of Marketing and Product Development, and the SVP Operations for Roche Molecular Diagnostics.

In his most recent roles, he co-founded and served as Chief Executive Officer of Clarient, a public Molecular Pathology Lab which was sold to General Electric Healthcare in December 2010. After which, he became the President of the Medical Sciences Venture for Life Technologies, and post-acquisition by Thermo Fisher Scientific, he stepped into the President of the Genetic Science Division for Thermo. He is a passionate ambassador for democratization of molecular diagnostic testing into community-based environments to better manage deadly diseases like cancer.